Healthcare provider profile · identity verified

James R Cicchiello, MD

General Practice · LOUISVILLE, KY · NPI 1730144296

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	602	95
Atorvastatin Calcium	Atorvastatin Calcium	408	121
Levothyroxine Sodium	Levothyroxine Sodium	365	103
Alprazolam	Alprazolam	348	64
Metoprolol Succinate	Metoprolol Succinate	345	98
Amlodipine Besylate	Amlodipine Besylate	331	92
Pantoprazole Sodium	Pantoprazole Sodium	237	75
Furosemide	Furosemide	214	75
Rosuvastatin Calcium	Rosuvastatin Calcium	214	73
Omeprazole	Omeprazole	203	63
Losartan Potassium	Losartan Potassium	196	60
Lisinopril	Lisinopril	184	58
Gabapentin	Gabapentin	180	60
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	180	25
Famotidine	Famotidine	171	55
Metformin Hcl	Metformin Hcl	170	48
Eliquis	Apixaban	145	28
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	141	37
Clonazepam	Clonazepam	133	24
Tamsulosin Hcl	Tamsulosin Hcl	131	40
Albuterol Sulfate Hfa	Albuterol Sulfate	129	46
Montelukast Sodium	Montelukast Sodium	123	34
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	122	35
Zolpidem Tartrate	Zolpidem Tartrate	119	18
Simvastatin	Simvastatin	113	33
Metoprolol Tartrate	Metoprolol Tartrate	106	31
Clopidogrel	Clopidogrel Bisulfate	103	35
Glimepiride	Glimepiride	100	27
Potassium Chloride	Potassium Chloride	100	41
Pravastatin Sodium	Pravastatin Sodium	98	28
Fluticasone Propionate	Fluticasone Propionate	96	35
Trazodone Hcl	Trazodone Hcl	94	34
Allopurinol	Allopurinol	92	30
Hydrochlorothiazide	Hydrochlorothiazide	92	28
Tramadol Hcl	Tramadol Hcl	78	22
Metformin Hcl Er	Metformin Hcl	77	27
Hydralazine Hcl	Hydralazine Hcl	64	19
Diclofenac Sodium	Diclofenac Sodium	63	23
Carvedilol	Carvedilol	61	23
Isosorbide Mononitrate Er	Isosorbide Mononitrate	61	15
Meloxicam	Meloxicam	61	21
Fluoxetine Hcl	Fluoxetine Hcl	58	20
Atenolol	Atenolol	57	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	19
Sertraline Hcl	Sertraline Hcl	57	21
Alendronate Sodium	Alendronate Sodium	56	16
Diazepam	Diazepam	54	14
Baclofen	Baclofen	53	13
Bupropion Xl	Bupropion Hcl	53	17
Escitalopram Oxalate	Escitalopram Oxalate	51	16
Promethazine Hcl	Promethazine Hcl	50	17
Tizanidine Hcl	Tizanidine Hcl	49	12
Ezetimibe	Ezetimibe	46	15
Pregabalin	Pregabalin	43	suppressed
Lorazepam	Lorazepam	40	suppressed
Benazepril Hcl	Benazepril Hcl	39	12
Amitriptyline Hcl	Amitriptyline Hcl	38	13
Celecoxib	Celecoxib	38	12
Warfarin Sodium	Warfarin Sodium	38	13
Jardiance	Empagliflozin	37	11
Spironolactone	Spironolactone	37	13
Methocarbamol	Methocarbamol	36	11
Azithromycin	Azithromycin	35	28
Duloxetine Hcl	Duloxetine Hcl	35	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	35	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	suppressed
Synthroid	Levothyroxine Sodium	34	11
Prednisone	Prednisone	33	25
Bumetanide	Bumetanide	31	12
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	31	suppressed
Glipizide Er	Glipizide	31	suppressed
Lovastatin	Lovastatin	31	suppressed
Hydrocortisone	Hydrocortisone	30	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	11
Vitamin D2	Ergocalciferol (Vitamin D2)	30	suppressed
Amoxicillin	Amoxicillin	29	23
Fenofibrate	Fenofibrate Nanocrystallized	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	12
Xarelto	Rivaroxaban	29	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	11
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Nitroglycerin	Nitroglycerin	27	15
Ondansetron Odt	Ondansetron	27	12
Valacyclovir	Valacyclovir Hcl	26	13
Azelastine Hcl	Azelastine Hcl	25	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	18
Methylprednisolone	Methylprednisolone	25	23
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	19
Ibuprofen	Ibuprofen	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	23	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Naproxen	Naproxen	23	suppressed
Cephalexin	Cephalexin	22	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Ozempic	Semaglutide	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Fluconazole	Fluconazole	20	11
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Butalbital-Aspirin-Caffeine	Butalbital/Aspirin/Caffeine	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Gemfibrozil	Gemfibrozil	19	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	18	suppressed
Eszopiclone	Eszopiclone	18	suppressed
Glipizide	Glipizide	18	suppressed
Valsartan	Valsartan	18	suppressed
Verapamil Er	Verapamil Hcl	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	15	suppressed
Dupixent Syringe	Dupilumab	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Ibu	Ibuprofen	15	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Flecainide Acetate	Flecainide Acetate	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Torsemide	Torsemide	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Betamethasone Valerate	Betamethasone Valerate	12	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	12	suppressed
Insulin Aspart Flexpen	Insulin Aspart	12	suppressed
Movantik	Naloxegol Oxalate	12	suppressed
Temazepam	Temazepam	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Digoxin	Digoxin	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error